In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take ...

Franklin Resources trimmed its Pfizer stake by a smidge, selling just 25,315 shares—but when you’ve got over 16 million, ...

Cola, Molina Healthcare and TJX buck historic market selloff as the Dow Jones Industrial Average falls 1,679 points.

However, Pfizer and Moderna's revenue and earnings dropped significantly once the pandemic receded, as did their share prices ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

StoneX Group clearly didn’t skip leg day—it just bulked up its Pfizer holdings by a massive 43.5% in Q4, scooping up over ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

At present, Healthcare’s dividend yield is 7.3% at 31 cents per share. Over a year, HR stock is up nearly 20%, effectively ...